Privium Fund Management B.V. Arrowhead Pharmaceuticals, Inc. Transaction History

Privium Fund Management B.V.

$551 Million
Q3 2025

A detailed history of Privium Fund Management B.V. transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Privium Fund Management B.V. holds 473,951 shares of ARWR stock, worth $19.6 Million. This represents 2.97% of its overall portfolio holdings.

Number of Shares

473,951

Previous 612,214 22.58%

Holding current value

$19.6 Million

Previous $9.67 Million 69.0%

% of portfolio

2.97%

Previous 2.06%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 03, 2025	SELL	$14.71 - $34.49 $2.03 Million - $4.77 Million	-138,263 Reduced 22.58%	473,951 $16.3 Million
Q2 2025 Jul 30, 2025	SELL	$9.99 - $16.97 $169,830 - $288,490	-17,000 Reduced 2.7%	612,214 $9.67 Million
Q1 2025 May 08, 2025	BUY	$12.74 - $21.53 $3.17 Million - $5.35 Million	248,628 Added 65.33%	629,214 $8.02 Million
Q4 2024 Feb 10, 2025	BUY	$17.7 - $26.34 $835,971 - $1.24 Million	47,230 Added 14.17%	380,586 $7.16 Million
Q3 2024 Nov 01, 2024	BUY	$19.36 - $29.54 $898,691 - $1.37 Million	46,420 Added 16.18%	333,356 $6.45 Million

Q2 2024 Jul 31, 2024	BUY	$21.87 - $28.24 $284,310 - $367,120	13,000 Added 4.75%	286,936 $7.46 Million
Q4 2023 Feb 13, 2024	BUY	$21.2 - $31.03 $315,880 - $462,347	14,900 Added 5.75%	273,936 $8.38 Million
Q1 2023 May 03, 2023	BUY	$23.68 - $38.51 $900,337 - $1.46 Million	38,021 Added 17.2%	259,036 $6.58 Million
Q4 2022 Feb 02, 2023	BUY	$28.0 - $40.56 $1.28 Million - $1.85 Million	45,622 Added 26.01%	221,015 $8.96 Million
Q2 2022 Jul 28, 2022	SELL	$27.79 - $50.61 $203,533 - $370,667	-7,324 Reduced 4.01%	175,393 $6.18 Million
Q1 2022 May 10, 2022	SELL	$39.62 - $69.97 $858,803 - $1.52 Million	-21,676 Reduced 10.61%	182,717 $8.4 Million
Q4 2021 Feb 09, 2022	BUY	$58.09 - $82.51 $11.9 Million - $16.9 Million	204,393 New	204,393 $13.8 Million

Others Institutions Holding ARWR

# of Institutions

339

Shares Held

103M

Call Options Held

953K

Put Options Held

263K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $4.37B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Privium Fund Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Privium Fund Management B.V. with notifications on news.

Account

Privium Fund Management B.V. Arrowhead Pharmaceuticals, Inc. Transaction History